Cited by 303Cellular Mechanics and InteractionsCancer Cells and MetastasisOvarian cancer diagnosis and treatment

Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium

Open access
Iwanicki, Marcin P., Davidowitz, Rachel A., Ng, Mei Rosa, Besser, Achim, Muranen, Taru, Merritt, Melissa, Danuser, Gaudenz, Ince, Tan +1 more·2011·Cancer Discovery

Published version of a preprint

Abstract

Abstract Dissemination of ovarian tumors involves the implantation of cancer spheroids into the mesothelial monolayer on the walls of peritoneal and pleural cavity organs. Biopsies of tumors attached to peritoneal organs show that mesothelial cells are not present under tumor masses. We have developed a live, image-based in vitro model in which interactions between tumor spheroids and mesothelial cells can be monitored in real time to provide spatial and temporal understanding of mesothelial clearance. In this article, we provide evidence that ovarian cancer spheroids use integrin- and talin-dependent activation of myosin and traction force to promote displacement of mesothelial cells from underneath a tumor cell spheroid. These results suggest that ovarian tumor cell clusters gain access to the submesothelial environment by exerting force on the mesothelial cells lining target organs, driving migration and clearance of the mesothelial cells. Significance: This study uses time-lapse video microscopy to decipher cellular events associated with ovarian tumor cell intercalation of mesothelial cell layers. Ovarian cancer clusters were found to use actomyosin-generated force to physically displace mesothelial cells and gain access to the submesothelial environment. Blockade of force-conducting molecules, including α5 integrin, talin I, and nonmuscle myosin II, in cancer cells abrogated mesothelial displacement from underneath attached cancer spheroids. Cancer Discovery; 1(2); 144–57. ©2011 AACR. Read the Commentary on this article by Kenny et al., p. 100 This article is highlighted in the In This Issue feature, p. 91

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8274.cd-11-0010

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Three-dimensional co-culture systems of ovarian cancers and mesothelial cells, including the organotypic omental mesothelium model, have enabled the study of mechanisms driving peritoneal and omental metastasis.

    “Three-dimensional co-culture systems of ovarian cancers and mesothelial cells, including the organotypic omental mesothelium model (described in Section 5.2.4) have also enabled the study of mechanisms driving peritoneal and omental metastasis (Iwanicki et al., 2011; Henry et al., 2017; Shishido et al., 2018; Loessner et al., 2019).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Iwanicki, M. P., Davidowitz, R. A., Ng, M. R., Besser, A., Muranen, T., Merritt, M., Danuser, G., Ince, T., & Brugge, J. S.
Affiliations
Brigham and Women's Hospital (US)
Venue
Cancer Discovery
Published
2011-07-01
Volume
1
Issue
2
Pages
144-157
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W2100926855
Cited by
303
References
38
Citations by year
2026: 12 · 2025: 16 · 2024: 16 · 2023: 28 · 2022: 29 · 2021: 20 · 2020: 24 · 2019: 26 · 2018: 18 · 2017: 19 · 2016: 13 · 2015: 20 · 2014: 29 · 2013: 16 · 2012: 10
FWCI
9.35
Type
journal article
Language
en
Open access
Locations
  • Cancer Discovery (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • American Association for Cancer Research
  • U.S. Public Health Service (5695837)
  • National Cancer Institute (R01CA105134)
  • National Institute of General Medical Sciences (R01GM071868)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
Keywords
ovarian cancer, tumor spheroids, mesothelial cells, mesothelial clearance, myosin II, actomyosin force, traction force, integrin alpha5, metastasis, peritoneal cavity
MeSH terms
Cell Adhesion, Epithelium, Female, Fibronectins, Humans, Ovarian Neoplasms, Peritoneal Cavity, Peritoneum, Tumor Cells, Cultured, Talin, Spheroids, Cellular, Myosin Type II, Integrin alpha5beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review